ID   S15A1_RAT               Reviewed;         710 AA.
AC   P51574; Q5EML1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-OCT-2024, entry version 141.
DE   RecName: Full=Solute carrier family 15 member 1;
DE   AltName: Full=Intestinal H(+)/peptide cotransporter {ECO:0000303|PubMed:8605246};
DE   AltName: Full=Oligopeptide transporter, small intestine isoform {ECO:0000303|PubMed:8605246};
DE   AltName: Full=Peptide transporter 1 {ECO:0000303|PubMed:8605246};
DE   AltName: Full=Proton-coupled dipeptide cotransporter;
GN   Name=Slc15a1; Synonyms=Pept1 {ECO:0000303|PubMed:8605246};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Small intestine;
RX   PubMed=8605246; DOI=10.1016/0167-4781(95)00208-1;
RA   Miyamoto K., Shiraga T., Morita K., Yamamoto H., Haga H., Taketani Y.,
RA   Tamai I., Sai Y., Tsuji A., Takeda E.;
RT   "Sequence, tissue distribution and developmental changes in rat intestinal
RT   oligopeptide transporter.";
RL   Biochim. Biophys. Acta 1305:34-38(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8531138;
RA   Saito H., Okuda M., Terada T., Sasaki S., Inui K.;
RT   "Cloning and characterization of a rat H+/peptide cotransporter mediating
RT   absorption of beta-lactam antibiotics in the intestine and kidney.";
RL   J. Pharmacol. Exp. Ther. 275:1631-1637(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE PROMOTER USAGE, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=15684415; DOI=10.1074/jbc.m414587200;
RA   Gaildrat P., Moller M., Mukda S., Humphries A., Carter D.A., Ganapathy V.,
RA   Klein D.C.;
RT   "A novel pineal-specific product of the oligopeptide transporter PepT1
RT   gene: circadian expression mediated by cAMP activation of an intronic
RT   promoter.";
RL   J. Biol. Chem. 280:16851-16860(2005).
RN   [4]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=19103603; DOI=10.1074/jbc.m808394200;
RA   Bailey M.J., Coon S.L., Carter D.A., Humphries A., Kim J.S., Shi Q.,
RA   Gaildrat P., Morin F., Ganguly S., Hogenesch J.B., Weller J.L., Rath M.F.,
RA   Moller M., Baler R., Sugden D., Rangel Z.G., Munson P.J., Klein D.C.;
RT   "Night/day changes in pineal expression of >600 genes: central role of
RT   adrenergic/cAMP signaling.";
RL   J. Biol. Chem. 284:7606-7622(2009).
CC   -!- FUNCTION: Electrogenic proton-coupled amino-acid transporter that
CC       transports oligopeptides of 2 to 4 amino acids with a preference for
CC       dipeptides. Transports neutral and monovalently charged peptides with a
CC       proton to peptide stoichiometry of 1:1 or 2:1 (By similarity).
CC       Primarily responsible for the absorption of dietary di- and tripeptides
CC       from the small intestinal lumen (By similarity). Mediates
CC       transepithelial transport of muramyl and N-formylated bacterial
CC       dipeptides contributing to recognition of pathogenic bacteria by the
CC       mucosal immune system (By similarity). {ECO:0000250|UniProtKB:P36836,
CC       ECO:0000250|UniProtKB:P46059}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dipeptide(out) + H(+)(out) = a dipeptide(in) + H(+)(in);
CC         Xref=Rhea:RHEA:64392, ChEBI:CHEBI:15378, ChEBI:CHEBI:90799;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64393;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-amino acid tripeptide(out) + H(+)(out) = an L-amino acid
CC         tripeptide(in) + H(+)(in); Xref=Rhea:RHEA:64400, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155837; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64401;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-alanyl-L-lysine(out) = H(+)(in) + L-alanyl-L-
CC         lysine(in); Xref=Rhea:RHEA:72611, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:192470; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72612;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-alanyl-L-proline(out) = H(+)(in) + L-alanyl-L-
CC         proline(in); Xref=Rhea:RHEA:64420, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155848; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64421;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-alanyl-L-valine(out) = H(+)(in) + L-alanyl-L-
CC         valine(in); Xref=Rhea:RHEA:72615, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:192471; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72616;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=carnosine(out) + H(+)(out) = carnosine(in) + H(+)(in);
CC         Xref=Rhea:RHEA:64404, ChEBI:CHEBI:15378, ChEBI:CHEBI:57485;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64405;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-L-glutamine(out) + H(+)(out) = glycyl-L-glutamine(in) +
CC         H(+)(in); Xref=Rhea:RHEA:71671, ChEBI:CHEBI:15378, ChEBI:CHEBI:74392;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71672;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71673;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-L-leucine(out) + H(+)(out) = glycyl-L-leucine(in) +
CC         H(+)(in); Xref=Rhea:RHEA:71675, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:143163; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71676;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-L-proline(out) + H(+)(out) = glycyl-L-proline(in) +
CC         H(+)(in); Xref=Rhea:RHEA:64428, ChEBI:CHEBI:15378, ChEBI:CHEBI:73779;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64429;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-sarcosine(out) + H(+)(out) = glycyl-sarcosine(in) +
CC         H(+)(in); Xref=Rhea:RHEA:64396, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155838; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64397;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-leucyl-L-leucine(out) = H(+)(in) + L-leucyl-L-
CC         leucine(in); Xref=Rhea:RHEA:71715, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:191208; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71716;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-leucyl-L-proline(out) = H(+)(in) + L-leucyl-L-
CC         proline(in); Xref=Rhea:RHEA:64424, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155847; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64425;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-phenylalanyl-L-leucine(out) = H(+)(in) + L-
CC         phenylalanyl-L-leucine(in); Xref=Rhea:RHEA:71699, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:190710; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71700;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-phenylalanyl-L-phenylalanine(out) = H(+)(in) +
CC         L-phenylalanyl-L-phenylalanine(in); Xref=Rhea:RHEA:71707,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:191205;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71708;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-lysyl-glycine(out) = H(+)(in) + L-lysyl-
CC         glycine(in); Xref=Rhea:RHEA:71679, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:191202; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71680;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71681;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-tyrosylglycine(out) = H(+)(in) + L-
CC         tyrosylglycine(in); Xref=Rhea:RHEA:71711, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:191210; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71712;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + L-alanyl-L-aspartate(out) = 2 H(+)(in) + L-
CC         alanyl-L-aspartate(in); Xref=Rhea:RHEA:71695, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:74363; Evidence={ECO:0000250|UniProtKB:P36836,
CC         ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71696;
CC         Evidence={ECO:0000250|UniProtKB:P36836,
CC         ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + L-aspartyl-glycine(out) = 2 H(+)(in) + L-
CC         aspartyl-glycine(in); Xref=Rhea:RHEA:71683, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:191203; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71684;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-L-aspartate(out) + 2 H(+)(out) = glycyl-L-aspartate(in)
CC         + 2 H(+)(in); Xref=Rhea:RHEA:71687, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:191204; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71688;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71689;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyl-L-glutamate(out) + 2 H(+)(out) = glycyl-L-glutamate(in)
CC         + 2 H(+)(in); Xref=Rhea:RHEA:71691, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:73784; Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71692;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-alanyl-L-leucyl-L-alanine(out) = H(+)(in) + L-
CC         alanyl-L-leucyl-L-alanine(in); Xref=Rhea:RHEA:71723,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:191212;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71724;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-alanyl-L-prolylglycine(out) = H(+)(in) + L-
CC         alanyl-L-prolylglycine(in); Xref=Rhea:RHEA:64432, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155849; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64433;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycylglycyl-L-isoleucine(out) + H(+)(out) = glycylglycyl-L-
CC         isoleucine(in) + H(+)(in); Xref=Rhea:RHEA:64436, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155850; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64437;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycylglycyl-L-proline(out) + H(+)(out) = glycylglycyl-L-
CC         proline(in) + H(+)(in); Xref=Rhea:RHEA:64440, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:155851; Evidence={ECO:0000250|UniProtKB:P46059};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64441;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + L-methionyl-L-phenylalanyl-L-methionine(out) =
CC         H(+)(in) + L-methionyl-L-phenylalanyl-L-methionine(in);
CC         Xref=Rhea:RHEA:71719, ChEBI:CHEBI:15378, ChEBI:CHEBI:191211;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71720;
CC         Evidence={ECO:0000250|UniProtKB:P36836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine(out)
CC         = 2 H(+)(in) + N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine(in);
CC         Xref=Rhea:RHEA:64408, ChEBI:CHEBI:15378, ChEBI:CHEBI:155830;
CC         Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+)(out) + N-formyl-L-methionyl-L-leucyl-L-
CC         phenylalanine(out) = 2 H(+)(in) + N-formyl-L-methionyl-L-leucyl-L-
CC         phenylalanine(in); Xref=Rhea:RHEA:75399, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:194314; Evidence={ECO:0000250|UniProtKB:P46059};
CC   -!- SUBUNIT: Interacts (via extracellular domain region) with trypsin.
CC       {ECO:0000250|UniProtKB:Q9JIP7}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000250|UniProtKB:P46059}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Localized to the apical membrane of enterocytes.
CC       {ECO:0000250|UniProtKB:P46059}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51574-1; Sequence=Displayed;
CC       Name=2; Synonyms=pgPepT1;
CC         IsoId=P51574-2; Sequence=VSP_042081, VSP_042082;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Highly expressed in small intestine.
CC       {ECO:0000269|PubMed:8531138, ECO:0000269|PubMed:8605246}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expression is restricted to
CC       pinealocytes. {ECO:0000269|PubMed:15684415,
CC       ECO:0000269|PubMed:19103603}.
CC   -!- INDUCTION: [Isoform 2]: Exhibits night/day variations with close to
CC       100-fold increased expression at night (PubMed:15684415,
CC       PubMed:19103603). Up-regulation is due to a large degree to the release
CC       of norepinephrine from nerve terminals in the pineal gland and cAMP
CC       signaling pathway, which activates an alternative promoter within
CC       intron 20 resulting in isoform 2 production (PubMed:15684415,
CC       PubMed:19103603). Levels rapidly decrease after exposure to daylight
CC       and become undetectable at midday and late afternoon (PubMed:15684415,
CC       PubMed:19103603). {ECO:0000269|PubMed:15684415,
CC       ECO:0000269|PubMed:19103603}.
CC   -!- DOMAIN: The extracellular domain (ECD) region specifically binds
CC       trypsin. {ECO:0000250|UniProtKB:Q9JIP7}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Proton-
CC       dependent oligopeptide transporter (POT/PTR) (TC 2.A.17) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D50664; BAA09318.1; -; mRNA.
DR   EMBL; D50306; BAA08844.1; -; mRNA.
DR   EMBL; AY860424; AAW80389.1; -; mRNA.
DR   PIR; S72497; S72497.
DR   RefSeq; NP_001073307.1; NM_001079838.1. [P51574-2]
DR   RefSeq; NP_476462.1; NM_057121.1.
DR   AlphaFoldDB; P51574; -.
DR   SMR; P51574; -.
DR   STRING; 10116.ENSRNOP00000015890; -.
DR   BindingDB; P51574; -.
DR   ChEMBL; CHEMBL2073691; -.
DR   TCDB; 2.A.17.4.1; the proton-dependent oligopeptide transporter (pot/ptr) family.
DR   GlyCosmos; P51574; 5 sites, No reported glycans.
DR   GlyGen; P51574; 5 sites.
DR   PhosphoSitePlus; P51574; -.
DR   PaxDb; 10116-ENSRNOP00000015890; -.
DR   GeneID; 117261; -.
DR   KEGG; rno:117261; -.
DR   AGR; RGD:621736; -.
DR   CTD; 6564; -.
DR   RGD; 621736; Slc15a1.
DR   eggNOG; KOG1237; Eukaryota.
DR   InParanoid; P51574; -.
DR   OrthoDB; 930761at2759; -.
DR   PhylomeDB; P51574; -.
DR   Reactome; R-RNO-427975; Proton/oligopeptide cotransporters.
DR   PRO; PR:P51574; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0005903; C:brush border; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0016248; F:channel inhibitor activity; IDA:RGD.
DR   GO; GO:0071916; F:dipeptide transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015333; F:peptide:proton symporter activity; ISS:UniProtKB.
DR   GO; GO:0005427; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0042937; F:tripeptide transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0140206; P:dipeptide import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0072237; P:metanephric proximal tubule development; IEP:RGD.
DR   GO; GO:0051956; P:negative regulation of amino acid transport; IDA:RGD.
DR   GO; GO:0006857; P:oligopeptide transport; ISO:RGD.
DR   GO; GO:0015833; P:peptide transport; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 2.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004768; Oligopep_transport.
DR   InterPro; IPR000109; POT_fam.
DR   InterPro; IPR018456; PTR2_symporter_CS.
DR   NCBIfam; TIGR00926; 2A1704; 1.
DR   PANTHER; PTHR11654; OLIGOPEPTIDE TRANSPORTER-RELATED; 1.
DR   PANTHER; PTHR11654:SF89; SOLUTE CARRIER FAMILY 15 MEMBER 1; 1.
DR   Pfam; PF00854; PTR2; 2.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS01022; PTR2_1; 1.
DR   PROSITE; PS01023; PTR2_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Cell membrane; Glycoprotein; Membrane;
KW   Peptide transport; Protein transport; Reference proteome; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..710
FT                   /note="Solute carrier family 15 member 1"
FT                   /id="PRO_0000064307"
FT   TRANSMEM        1..21
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        22..53
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        54..74
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        75..82
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        83..103
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        104..118
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        119..139
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        140..161
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        162..182
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        183..198
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        199..219
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        220..276
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..297
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        298..327
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        328..348
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        349..361
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        362..382
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        383..586
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        587..607
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        608..621
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        622..642
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        643..647
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        648..668
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        669..710
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          383..586
FT                   /note="Extracellular domain (ECD)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIP7"
FT   REGION          687..710
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        415
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        510
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        532
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        539
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..560
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15684415"
FT                   /id="VSP_042081"
FT   VAR_SEQ         561..563
FT                   /note="SRA -> MVQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15684415"
FT                   /id="VSP_042082"
FT   CONFLICT        241
FT                   /note="R -> G (in Ref. 2; BAA08844)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="N -> E (in Ref. 2; BAA08844)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279..280
FT                   /note="IM -> MV (in Ref. 2; BAA08844)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   710 AA;  78929 MW;  435727A6C76F2D7B CRC64;
     MGMSKSRGCF GYPLSIFFIV VNEFCERFSY YGMRALLVLY FRNFLGWDDD LSTAIYHTFV
     ALCYLTPILG ALIADSWLGK FKTIVSLSIV YTIGQAVISV SSINDLTDHD HDGSPNNLPL
     HVALSMIGLA LIALGTGGIK PCVSAFGGDQ FEEGQEKQRN RFFSIFYLAI NAGSLLSTII
     TPILRVQQCG IHSQQACYPL AFGVPAALMA VALIVFVLGS GMYKKFQPQG NIMGKVAKCI
     RFAIKNRFRH RSKAFPKRNH WLDWAKEKYD ERLISQIKIM TKVMFLYIPL PMFWALFDQQ
     GSRWTLQATT MTGKIGTIEI QPDQMQTVNA ILIVIMVPIV DAVVYPLIAK CGFNFTSLKK
     MTVGMFLASM AFVVAAIVQV EIDKTLPVFP SGNQVQIKVL NIGNNDMAVY FPGKNVTVAQ
     MSQTDTFMTF DVDQLTSINV SSPGSPGVTT VAHEFEPGHR HTLLVWGPNL YRVVKDGLNQ
     KPEKGENGIR FVSTLNEMIT IKMSGKVYEN VTSHSASNYQ FFPSGQKDYT INTTEIAPNC
     SSDFKSSNLD FGSAYTYVIR SRASDGCLEV KEFEDIPPNT VNMALQIPQY FLLTCGEVVF
     SVTGLEFSYS QAPSNMKSVL QAGWLLTVAI GNIIVLIVAE AGHFDKQWAE YVLFASLLLV
     VCIIFAIMAR FYTYINPAEI EAQFDEDEKK KGVGKENPYS SLEPVSQTNM
//
